The effect of methotrexate and 7-hydroxymethotrexate on rat adjuvant arthritis and on urinary aminoimidazole carboxamide excretion

Arthritis and Rheumatism

Volumn 41, Issue 8, 1998, Pages 1407-1410

  Baggott, Joseph E ^a   Morgan, Sarah L ^a   Koopman, William J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE; 7 HYDROXYMETHOTREXATE; FOLIC ACID ANTAGONIST; METHOTREXATE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; ARTHRITIS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID ANTAGONISTS; HINDLIMB; HYDROXYMETHYL AND FORMYL TRANSFERASES; JOINTS; METHOTREXATE; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE; RATS; RATS, INBRED LEW;

EID: 0031828355     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199808)41:8<1407::AID-ART9>3.0.CO;2-H     Document Type: Article

References (15)

1. Stewart AL, Margison JM, Wilkinson PM, Lucas SB. The pharmacokinetics of 7-hydroxy-methotrexate following medium-dose methotrexate therapy. Cancer Chemother Pharmacol 1985;14: 165-7.
2. Sonneweld P, Schultz FW, Nooter K, Hahlen K. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate. Cancer Chemother Pharmacol 1986;18:111-6.
3. Seideman P, Beck O, Ekshorg S, Wennberg M. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis. Br J Clin Pharmacol 1993;35:409-12.
4. Smeland E, Fuskevag OM, Nymann K, Svendsen JS, Olsen R, Lindal S, et al. High dose 7-hydroxymethotrexate: acute toxicity and lethality in a rat model. Cancer Chemother Pharmacol 1996;37:415-22.
5. McGeer PL, McGeer EG. Effect of amethopterin and vincaleukoblastine on urinary 4-amino-5-imidazolecarboxamide. Biochem Pharmacol 1963;12:297-8.
6. 12 and folic acid deficiencies. Lancet 1962;2: 1381-2.
7. Baggott JE, Morgan SL, Ha TS, Alarcón GS, Koopman WJ, Krumdieck CL. Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol 1993;11 Suppl 8:101-5.
8. Baggott JE, Morgan SL, Vaughn WH. Differences in methotrexate and 7-hydroxymethotrexate inhibition of folate dependent enzymes of purine nucleotide biosynthesis. Biochem J 1994;300: 627-9.
9. Welles WL, Silkworth J, Oronsky AL, Kerwar SS, Galivan J. Studies on the effect of low dose methotrexate on rat adjuvant arthritis. J Rheumatol 1985;12:904-6.
10. O'Sullivan FX, Fassbender H-G, Gay S, Koopman WJ. Etiopathogensis of the rheumatoid arthritis-like disease in MRL/1 mice. I. The histomorphologic basis of joint destruction. Arthritis Rheum 1985;28:529-36.
11. Baggott JE, Morgan SL, Freeberg LE, Hudson BB, Vaughn WH, Nair MG, et al. Long term treatment of the MRL/lpr mouse with methotrexate and 10-deazaaminopterin. Agents Actions 1992;35: 104-11.
12. McGeer PL, McGeer EG, Griffin MC. Excretion of 4-amino-5-imidazole-carboxamide in human urine. Can J Biochem Physiol 1961;39:591-603.
13. Baggott JE, Johanning GL, Branham KE, Prince CW, Morgan SL, Eto I, et al. Cofactor role for 10-formyldihydrofolic acid. Biochem J 1995;308:1031-6.
14. 12 deficient rats. Can J Biochem 1963;43:1367-74.
15. Slordal L, Jaeger R, Kjaeve J, Aarbakke J. Pharmacokinetics of 7-hydroxy-methotrexate in the rat. Pharmacol Toxicol 1988;63:81-4.